102 related articles for article (PubMed ID: 8305393)
21. Progression of atypical endometrial hyperplasia to adenocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intrauterine system.
Kresowik J; Ryan GL; Van Voorhis BJ
Obstet Gynecol; 2008 Feb; 111(2 Pt 2):547-9. PubMed ID: 18239018
[TBL] [Abstract][Full Text] [Related]
22. Expression of estrogen receptors ERalpha and ERbeta in endometrial hyperplasia and adenocarcinoma.
Hu K; Zhong G; He F
Int J Gynecol Cancer; 2005; 15(3):537-41. PubMed ID: 15882182
[TBL] [Abstract][Full Text] [Related]
23. [Difficulties and mistakes in the diagnosis of atypical endometrial hyperplasia].
Kxmel'nitskaia NM; Neĭshtadt EL; Khalimdzhanov ZK
Arkh Patol; 2006; 68(6):39-42. PubMed ID: 17290894
[TBL] [Abstract][Full Text] [Related]
24. [Drugs in development for the treatment of osteoporosis: Tibolone].
Gorai I
Nihon Rinsho; 2002 Mar; 60 Suppl 3():552-71. PubMed ID: 11979954
[No Abstract] [Full Text] [Related]
25. [The relationship between simple and atypical endometrial hyperplasia and endometrial carcinoma].
Borisov I; Maĭnkhard K; Tsankova M
Akush Ginekol (Sofiia); 1996; 35(4):18-20. PubMed ID: 9254559
[TBL] [Abstract][Full Text] [Related]
26. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
[TBL] [Abstract][Full Text] [Related]
27. Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments.
Norimatsu Y; Shimizu K; Kobayashi TK; Moriya T; Tsukayama C; Miyake Y; Ohno E
Cancer; 2006 Apr; 108(2):77-85. PubMed ID: 16463402
[TBL] [Abstract][Full Text] [Related]
28. [Endometrial hyperplasia and carcinoma in situ].
Ganchev S; Maĭnkhard K
Akush Ginekol (Sofiia); 1997; 36(3):47-50. PubMed ID: 9618961
[TBL] [Abstract][Full Text] [Related]
29. The process of carcinogenesis for endometrial adenocarcinoma could be short: development of a malignancy after endometrial ablation.
Ramey JW; Koonings PP; Given FT; Acosta AA
Am J Obstet Gynecol; 1994 May; 170(5 Pt 1):1370-1. PubMed ID: 8178868
[TBL] [Abstract][Full Text] [Related]
30. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Chin J; Konje JC; Hickey M
Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
[TBL] [Abstract][Full Text] [Related]
31. Endometrial hyperplasia and carcinoma in endometrial polyps: clinicopathologic and follow-up findings.
Mittal K; Da Costa D
Int J Gynecol Pathol; 2008 Jan; 27(1):45-8. PubMed ID: 18156974
[TBL] [Abstract][Full Text] [Related]
32. Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment.
Horn LC; Schnurrbusch U; Bilek K; Hentschel B; Einenkel J
Int J Gynecol Cancer; 2004; 14(2):348-53. PubMed ID: 15086736
[TBL] [Abstract][Full Text] [Related]
33. The incidence of vaginal bleeding with tibolone treatment.
Rymer J; Fogelman I; Chapman MG
Br J Obstet Gynaecol; 1994 Jan; 101(1):53-6. PubMed ID: 8297869
[TBL] [Abstract][Full Text] [Related]
34. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
[TBL] [Abstract][Full Text] [Related]
35. Taking another look at endometrial adenocarcinoma.
Zaino RJ
Int J Gynecol Pathol; 1996 Jul; 15(3):187-90. PubMed ID: 8811378
[No Abstract] [Full Text] [Related]
36. Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy.
Thom MH; White PJ; Williams RM; Sturdee DW; Paterson ME; Wade-Evans T; Studd JW
Lancet; 1979 Sep; 2(8140):455-7. PubMed ID: 89511
[TBL] [Abstract][Full Text] [Related]
37. Proliferative activity in endometrial hyperplasia and adenocarcinoma.
Terlikowski S; Lenczewski A; Famulski W; Sulkowska M; Kulikowski M
Folia Histochem Cytobiol; 2001; 39(2):163-4. PubMed ID: 11374806
[TBL] [Abstract][Full Text] [Related]
38. Does tamoxifen induce endometrial hyperplasia, carcinoma and polyps?
van den Bosch T; Vandendael A
S Afr Med J; 1994 Jun; 84(6):367-8. PubMed ID: 7740401
[No Abstract] [Full Text] [Related]
39. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
Hauth E; Libera H; Kimmig R; Forsting M
Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
[TBL] [Abstract][Full Text] [Related]
40. Endometrial hyperplasia and neoplasia. Cytologic screening with the Endopap endometrial sampler.
Meisels A; Fortier M; Jolicoeur C
J Reprod Med; 1983 May; 28(5):309-13. PubMed ID: 6152983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
